Posted by Michael Wonder on 20 Sep 2016
Biosimilar awareness initiative reference group communique
20 September 2016 - The communique from the third Reference Group meeting is now available.
The Biosimilar Awareness Initiative Reference Group (the Reference Group) was established to give guidance on the activities of the Biosimilar Awareness Initiative and ensure key messages are clearly articulated and appropriately targeted.
Members of the Reference Group consists of stakeholders from the pharmaceutical industry, consumers, pharmacists and relevant medical authorities.
The third meeting of the Reference Group was held in Canberra on 18 August 2016,
